February 7, 2017 / 12:41 PM / in 10 months

BRIEF-Anavex reports Q1 loss per share $0.08

Feb 7 (Reuters) - Anavex Life Sciences Corp -

* Anavex reports fiscal first quarter 2017 financial results

* Q1 loss per share $0.08

* Says it is now able to initiate subsequent placebo-controlled efficacy and safety trials for Anavex 2-73 in Alzheimer’s and Parkinson’s disease as well as rett syndrome Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below